|
1
|
Morrell NW, Adnot S, Archer SL, Dupuis J,
Jones PL, MacLean MR, McMurtry IF, Stenmark KR, Thistlethwaite PA,
Weissmann N, Yuan JX and Weir EK: Cellular and molecular basis of
pulmonary arterial hypertension. J Am Coll Cardiol. 54:S20–S31.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kanki-Horimoto S, Horimoto H, Mieno S,
Kishida K, Watanabe F, Furuya E and Katsumata T: Implantation of
mesenchymal stem cells overexpressing endothelial nitric oxide
synthases improves right ventricular impairments caused by
pulmonary hypertension. Circulation. 114:I181–I185. 2006.
|
|
3
|
Baber SR, Deng W, Master RG, Bunnell BA,
Taylor BK, Murthy SN, Hyman AL and Kadowitz PJ: Intratracheal
mesenchymal stem cell administration attenuates
monocrotaline-induced pulmonary hypertension and endothelial
dysfunction. Am J Physiol Heart Circ Physiol. 292:H1120–H1128.
2007. View Article : Google Scholar
|
|
4
|
Patel KM, Crisostomo P, Lahm T, Markel T,
Herring C, Wang M, Meldrum KK, Lillemoe KD and Meldrum DR:
Mesenchymal stem cells attenuate hypoxic pulmonary vasoconstriction
by a paracrine mechanism. J Surg Res. 143:281–285. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Miura M, Hirose M, Endoh H, Wakayama Y,
Sugai Y, Nakano M, Fukuda K, Shindoh C, Shirato K and Shimokawa H:
Acceleration of Ca2+ waves in monocrotaline-induced
right ventricular hypertrophy in the rat. Circ J. 75:1343–1349.
2011.
|
|
6
|
Wang CH, Cherng WJ, Yang NI, Kuo LT, Hsu
CM, Yeh HI, Lan YJ, Yeh CH and Stanford WL: Late-outgrowth
endothelial cells attenuate intimal hyperplasia contributed by
mesenchymal stem cells after vascular injury. Arterioscler Thromb
Vasc Biol. 28:54–60. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Westerweel PE and Verhaar MC: Directing
myogenic mesenchymal stem cell differentiation. Circ Res.
103:560–561. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Gehrke I, Gandhirajan RK, Poll-Wolbeck SJ,
Hallek M and Kreuzer KA: Bone marrow stromal cell-derived vascular
endothelial growth factor (VEGF) rather than chronic lymphocytic
leukemia (CLL) cell-derived VEGF is essential for the apoptotic
resistance of cultured CLL cells. Mol Med. 17:619–627. 2011.
View Article : Google Scholar
|
|
9
|
Crosswhite P and Sun Z: Nitric oxide,
oxidative stress and inflammation in pulmonary arterial
hypertension. J Hypertens. 28:201–212. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gao J, Dennis JE, Muzic RF, Lundberg M and
Caplan AI: The dynamic in vivo distribution of bone marrow-derived
mesenchymal stem cells after infusion. Cells Tissues Organs.
169:12–20. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nagaya N, Fujii T, Iwase T, Ohgushi H,
Itoh T, Uematsu M, Yamagishi M, Mori H, Kangawa K and Kitamura S:
Intravenous administration of mesenchymal stem cells improves
cardiac function in rats with acute myocardial infarction through
angiogenesis and myogenesis. Am J Physiol Heart Circ Physiol.
287:H2670–H2676. 2004. View Article : Google Scholar
|
|
12
|
Choudhary M, Zhang X, Stojkovic P, Hyslop
L, Anyfantis G, Herbert M, Murdoch AP, Stojkovic M and Lako M:
Putative role of hyaluronan and its related genes, HAS2 and RHAMM,
in human early preimplantation embryogenesis and embryonic stem
cell characterization. Stem Cells. 25:3045–3057. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luan Y, Liu XC, Zhang GW, Shi RF, Zhao XB,
Zhao CH, Liu TJ, Lü F, Yang Q and He GW: Mid-term effect of stem
cells combined with transmyocardial degradable stent on swine model
of acute myocardial infarction. Coron Artery Dis. 21:233–243. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Liu XC, Zhang GW, Zhao J, Zhang
JM, Shi RF, Huang YZ, Zhao CH, Liu TJ, Song CX, Lü F, Yang Q and He
GW: A new transmyocardial degradable stent combined with growth
factor, heparin, and stem cells in acute myocardial infarction.
Cardiovasc Res. 84:461–469. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jiang Y, Jahagirdar BN, Reinhardt RL,
Schwartz RE, Keene CD, Ortiz-Gonzalez XR, Reyes M, Lenvik T, Lund
T, Blackstad M, Du J, Aldrich S, Lisberg A, Low WC, Largaespada DA
and Verfaillie CM: Pluripotency of mesenchymal stem cells derived
from adult marrow. Nature. 418:41–49. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Oswald J, Boxberger S, Jørgensen B,
Feldmann S, Ehninger G, Bornhäuser M and Werner C: Mesenchymal stem
cells can be differentiated into endothelial cells in vitro. Stem
Cells. 22:377–384. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Luan Y, Zhang ZH, Wei DE, Zhao JJ, Kong F,
Cheng GH and Wang YB: Implantation of mesenchymal stem cells
improves right ventricular impairments caused by experimental
pulmonary hypertension. Am J Med Sci. 343:402–406. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Frid MG, Brunetti JA, Burke DL, Carpenter
TC, Davie NJ, Reeves JT, Roedersheimer MT, van Rooijen N and
Stenmark KR: Hypoxia-induced pulmonary vascular remodeling requires
recruitment of circulating mesenchymal precursors of a
monocyte/macrophage lineage. Am J Pathol. 168:659–669. 2006.
View Article : Google Scholar
|
|
19
|
Rochefort GY, Vaudin P, Bonnet N, Pages
JC, Domenech J, Charbord P and Eder V: Influence of hypoxia on the
domiciliation of mesenchymal stem cells after infusion into rats:
possibilities of targeting pulmonary artery remodeling via cells
therapies? Respir Res. 6:1252005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tang J, Xie Q, Pan G, Wang J and Wang M:
Mesenchymal stem cells participate in angiogenesis and improve
heart function in rat model of myocardial ischemia with
reperfusion. Eur J Cardiothorac Surg. 30:353–361. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jiang S, Kh Haider H, Ahmed RP, Idris NM,
Salim A and Ashraf M: Transcriptional profiling of young and old
mesenchymal stem cells in response to oxygen deprivation and
reparability of the infarcted myocardium. J Mol Cell Cardiol.
44:582–596. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Al-Khaldi A, Al-Sabti H, Galipeau J and
Lachapelle K: Therapeutic angiogenesis using autologous bone marrow
stromal cells: improved blood flow in a chronic limb ischemia
model. Ann Thorac Surg. 75:204–209. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Guo Y, He J, Wu J, Yang L, Dai S, Tan X
and Liang L: Locally overexpressing hepatocyte growth factor
prevents post-ischemic heart failure by inhibition of apoptosis via
calcineurin-mediated pathway and angiogenesis. Arch Med Res.
39:179–188. 2008. View Article : Google Scholar
|
